Phosphorylation of Ser307 in Insulin Receptor Substrate-1 Blocks Interactions with the Insulin Receptor and Inhibits Insulin Action
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Serine phosphorylation of insulin receptor substrate-1 (IRS-1) inhibits insulin signal transduction in a variety of cell backgrounds, which might contribute to peripheral insulin resistance. However, because of the large number of potential phosphorylation sites, the mechanism of inhibition has been difficult to determine. One serine residue located near the phosphotyrosine-binding (PTB) domain in IRS-1 (Ser(307) in rat IRS-1 or Ser(312) in human IRS-1) is phosphorylated via several mechanisms, including insulin-stimulated kinases or stress-activated kinases like JNK1. During a yeast tri-hybrid assay, phosphorylation of Ser(307) by JNK1 disrupted the interaction between the catalytic domain of the insulin receptor and the PTB domain of IRS-1. In 32D myeloid progenitor cells, phosphorylation of Ser(307) inhibited insulin stimulation of the phosphatidylinositol 3-kinase and MAPK cascades. These results suggest that inhibition of PTB domain function in IRS-1 by phosphorylation of Ser(307) (Ser(312) in human IRS-1) might be a general mechanism to regulate insulin signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Specifically, phosphorylation of these serine residues impedes the normal association of IRS-1 with the insulin receptor, thereby impairing downstream propagation of insulin signaling (16,19).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Dérijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M., & Davis, R. J. (1994) · Cell · doi:10.1016/0092-8674(94)90380-8 · Cited by 3,188
Cellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Self-citationStructure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein
Sun, X. J., Rothenberg, P., Kahn, C. R., Backer, J. M., Araki, E., Wilden, P. A., Cahill, D. A., Goldstein, B. J., & White, M. F. (1991) · Nature · doi:10.1038/352073a0 · Cited by 1,574
Self-citationAguirre, V., Uchida, T., Yenush, L., Davis, R., & White, M. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.9047 · Cited by 1,487
Self-citationKuan, C.-Y., Yang, D. D., Roy, D. R. S., Davis, R. J., Rakic, P., & Flavell, R. A. (1999) · Neuron · doi:10.1016/s0896-6273(00)80727-8 · Cited by 894
Protein–protein interaction in insulin signaling and the molecular mechanisms of insulin resistance
Virkamäki, A., Ueki, K., & Kahn, C. R. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6609 · Cited by 854
Role of IRS-2 in insulin and cytokine signalling
Sun, X. J., Wang, L.-M., Zhang, Y., Yenush, L., Myers Jr, M. G., Glasheen, E., Lane, W. S., Pierce, J. H., & White, M. F. (1995) · Nature · doi:10.1038/377173a0 · Cited by 848
Self-citationA Cytoplasmic Inhibitor of the JNK Signal Transduction Pathway
Dickens, M., Rogers, J. S., Cavanagh, J., Raitano, A., Xia, Z., Halpern, J. R., Greenberg, M. E., Sawyers, C. L., & Davis, R. J. (1997) · Science · doi:10.1126/science.277.5326.693 · Cited by 675
Research works printed but not linked: 6
- Maezono, K., Osman, A., Patti, M. E., Cusi, K., Pendergrass, M., DeFronzo, R. A., and Mandarino, L. (1998) Diabetes 47, 333A (abstr.)
- Carboni, J. M., Yan, N., Cox, A. D., Bustelo, X., Graham, S. M., Lynch, M. J., Weinmann, R., Seizinger, B. R., Der, C. J., Barbacid, M., and Manne, V. (1995) Oncogene 10, 1905-1913
- Myers, M. G., Jr., Wang, L. M., Sun, X. J., Zhang, Y., Yenush, L., Schlessinger, J., Pierce, J. H., and White, M. F. (1994) Mol. Cell. Biol. 14, 3577-3587
- Delahaye, L., Mothe-Satney, I., Myers, M. G., Jr., White, M. F., and Van Obberghen, E. (1998) Endocrinology 139, 4911-4919 · DOI · Paper page
- O'Neill, T. J., Craparo, A., and Gustafson, T. A. (1994) Mol. Cell. Biol. 14, 6433-6442
- Chin, J. E., Liu, F., and Roth, R. A. (1994) Mol. Endocrinol. 8, 51-58
Cited by
Items 101–200 of 999
Targeting PI3K/AKT signaling pathway in obesity
Savova, M. S., Mihaylova, L. V., Tews, D., Wabitsch, M., & Georgiev, M. I. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114244 · Cited by 277
Activation of SOCS-3 by Resistin
Steppan, C. M., Wang, J., Whiteman, E. L., Birnbaum, M. J., & Lazar, M. A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.4.1569-1575.2005 · Cited by 281
“TNF- and fatty acids lead to inhibitory phosphorylation of IRS-1 at Ser(307) via activation of jun amino-terminal kinase (JNK1) (1) and protein kinase C- , (43), respectively.”
BackgroundThe Role of Gut Microbiota on Insulin Resistance
Caricilli, A., & Saad, M. (2013) · Nutrients · doi:10.3390/nu5030829 · Cited by 274
“inhibitory κB kinase (IKK)-β, and decreased tyrosine phosphorylation of IRS-1 [71–76].”
BackgroundImpaired liver regeneration in Nrf2 knockout mice: role of ROS‐mediated insulin/IGF‐1 resistance
Beyer, T. A., Xu, W., Teupser, D., auf dem Keller, U., Bugnon, P., Hildt, E., Thiery, J., Kan, Y. W., & Werner, S. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601950 · Cited by 266
“JNK can phosphorylate IRS-1 at Ser307 (Ser312 in human IRS-1) and thereby inhibit its phosphorylation at Tyr608 (Tyr612 in human IRS-1) by the insulin or IGF-1 receptor (Aguirre et al, 2002).”
Carro, E., & Torres-Aleman, I. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.050 · Cited by 262
IKK mediates ischemia-induced neuronal death
Herrmann, O., Baumann, B., de Lorenzi, R., Muhammad, S., Zhang, W., Kleesiek, J., Malfertheiner, M., Köhrmann, M., Potrovita, I., Maegele, I., et al. (2005) · Nature Medicine · doi:10.1038/nm1323 · Cited by 259
“Phosphorylation of IRS-1 by IKK may impair activation of the neuroprotective kinase Ak”
BackgroundGao, Z., Zuberi, A., Quon, M. J., Dong, Z., & Ye, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300423200 · Cited by 258
Watanabe, M., Horai, Y., Houten, S. M., Morimoto, K., Sugizaki, T., Arita, E., Mataki, C., Sato, H., Tanigawara, Y., Schoonjans, K., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.248203 · Cited by 254
Insulin Resistance Due to Phosphorylation of Insulin Receptor Substrate-1 at Serine 302
Werner, E. D., Lee, J., Hansen, L., Yuan, M., & Shoelson, S. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405203200 · Cited by 252
Self-citationMouse models of insulin resistance
Hribal, M. L., Oriente, F., & Accili, D. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00561.2001 · Cited by 252
“tor (6) and is reduced in Jnk1 / mice (91).”
BackgroundMouse Models of Insulin Resistance
NANDI, A., KITAMURA, Y., KAHN, C. R., & ACCILI, D. (2004) · Physiological Reviews · doi:10.1152/physrev.00032.2003 · Cited by 231
Alterations of insulin signaling in type 2 diabetes: A review of the current evidence from humans
Fröjdö, S., Vidal, H., & Pirola, L. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.10.019 · Cited by 245
Prada, P. O., Zecchin, H. G., Gasparetti, A. L., Torsoni, M. A., Ueno, M., Hirata, A. E., Corezola do Amaral, M. E., Höer, N. F., Boschero, A. C., & Saad, M. J. A. (2005) · Endocrinology · doi:10.1210/en.2004-0767 · Cited by 244
Ugi, S., Imamura, T., Maegawa, H., Egawa, K., Yoshizaki, T., Shi, K., Obata, T., Ebina, Y., Kashiwagi, A., & Olefsky, J. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8778-8789.2004 · Cited by 243
“Several serine/threonine kinases responsible for phosphorylation of IRS-1 have been reported, including Akt (45), PKC (36, 46), JNK (2), IKK (21), and GSK-3 (20).”
BackgroundIL-6 and Serum Amyloid A Synergy Mediates Angiotensin II–Induced Muscle Wasting
Zhang, L., Du, J., Hu, Z., Han, G., Delafontaine, P., Garcia, G., & Mitch, W. E. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008060628 · Cited by 240
Selective Hepatic Insulin Resistance, VLDL Overproduction, and Hypertriglyceridemia
Sparks, J. D., Sparks, C. E., & Adeli, K. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.241463 · Cited by 231
β-cell failure as a complication of diabetes
Chang-Chen, K. J., Mullur, R., & Bernal-Mizrachi, E. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9101-5 · Cited by 225
“stress inhibits IRS1 signaling by phosphorylation of IRS-1 on Ser(307) [106, 107].”
Chapter 21 Interleukin‐6 and Insulin Resistance
Kim, J., Bachmann, R. A., & Chen, J. (2009) · Vitamins & Hormones · doi:10.1016/s0083-6729(08)00621-3 · Cited by 224
“For instance, the phosphorylation of Ser307 of IRS-1 (Ser312 in human IRS-1), located at the end of the phosphotyrosine-binding (PTB) domain, has been shown to block the interaction between IRS-1 and IR (Aguirre et al., 2002).”
BackgroundRegulation of insulin receptor function
Youngren, J. F. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6359-9 · Cited by 223
Turning Signals On and Off: GLUT4 Traffic in the Insulin-Signaling Highway
Thong, F. S. L., Dugani, C. B., & Klip, A. (2005) · Physiology · doi:10.1152/physiol.00017.2005 · Cited by 223
Lee, S., Keirsey, K. I., Kirkland, R., Grunewald, Z. I., Fischer, J. G., & de La Serre, C. B. (2018) · The Journal of Nutrition · doi:10.1093/jn/nxx027 · Cited by 222
Wang, P.-X., Ji, Y.-X., Zhang, X.-J., Zhao, L.-P., Yan, Z.-Z., Zhang, P., Shen, L.-J., Yang, X., Fang, J., Tian, S., et al. (2017) · Nature Medicine · doi:10.1038/nm.4290 · Cited by 221
The key role of growth hormone-insulin-IGF-1 signaling in aging and cancer
Anisimov, V. N., & Bartke, A. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.01.005 · Cited by 192
“The latter ffect likely reflects reduced activation of JNK1 and mTOR, actors known to promote insulin resistance by phosphoryating this or homologous sites of the IRS1 molecule [52,65].”
From chronic overnutrition to insulin resistance: The role of fat-storing capacity and inflammation
Lionetti, L., Mollica, M. P., Lombardi, A., Cavaliere, G., Gifuni, G., & Barletta, A. (2009) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.10.010 · Cited by 216
Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer’s Disease
Mullins, R. J., Diehl, T. C., Chia, C. W., & Kapogiannis, D. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00118 · Cited by 216
“…in reduced insulin receptor binding sensitivity and translocation of the active portion of IRS from the membrane to the cytosol, and is one of the main molecular underpinnings of insulin resistance (IR; Aguirre et al., 2002; Boura-Halfon and Zick, 2009; Copps andWhite, 2012; Ryu et al., 2014).”
BackgroundThe Immune System as a Sensor of the Metabolic State
Odegaard, J. I., & Chawla, A. (2013) · Immunity · doi:10.1016/j.immuni.2013.04.001 · Cited by 216
“In turn, these signaling pathways directly antagonize the insulin signaling pathway, primarily through inhibitory serine phosphorylation of insulin receptor substrate (IRS) proteins (Aguirre et al., 2002; Hotamisligil et al., 1996).”
Astaxanthin: A Potential Mitochondrial-Targeted Antioxidant Treatment in Diseases and with Aging
Sztretye, M., Dienes, B., Gönczi, M., Czirják, T., Csernoch, L., Dux, L., Szentesi, P., & Keller-Pintér, A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3849692 · Cited by 214
“JNK1 has a crucial role in the development of insulin resistance by inhibiting IRS activity via phosphorylation of Ser307 residue preventing its interaction with the insulin receptor [82, 83].”
BackgroundWang, C., Mao, X., Wang, L., Liu, M., Wetzel, M. D., Guan, K.-L., Dong, L. Q., & Liu, F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700098200 · Cited by 210
Bandyopadhyay, G. K., Yu, J. G., Ofrecio, J., & Olefsky, J. M. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2351 · Cited by 210
Andreozzi, F., Laratta, E., Sciacqua, A., Perticone, F., & Sesti, G. (2004) · Circulation Research · doi:10.1161/01.res.0000126501.34994.96 · Cited by 208
López‐Candales, A., Burgos, P. M. H., Hernández-Suárez, D. F., & Harris, D. A. (2017) · PubMed · Cited by 252
Pu, P., Gao, D.-M., Mohamed, S., Chen, J., Zhang, J., Zhou, X.-Y., Zhou, N.-J., Xie, J., & Jiang, H. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2011.11.026 · Cited by 203
Carter-Kent, C., Zein, N. N., & Feldstein, A. E. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01709.x · Cited by 203
Greene, M. W., Sakaue, H., Wang, L., Alessi, D. R., & Roth, R. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209153200 · Cited by 201
Rieusset, J., Bouzakri, K., Chevillotte, E., Ricard, N., Jacquet, D., Bastard, J.-P., Laville, M., & Vidal, H. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2232 · Cited by 200
Consequences of Lipid Droplet Coat Protein Downregulation in Liver Cells
Bell, M., Wang, H., Chen, H., McLenithan, J. C., Gong, D.-W., Yang, R.-Z., Yu, D., Fried, S. K., Quon, M. J., Londos, C., et al. (2008) · Diabetes · doi:10.2337/db07-1383 · Cited by 199
“IRS-1–Ser307 phosphorylation, which promotes general inhibition of IRS-1 signaling (17), was increased in cells lacking PAT proteins (Fig.”
BackgroundExpression and function of the insulin receptor substrate proteins in cancer
Mardilovich, K., Pankratz, S. L., & Shaw, L. M. (2009) · Cell Communication and Signaling · doi:10.1186/1478-811x-7-14 · Cited by 192
“For example, the inflammatory cytokine tumor necrosis factor-α (TNF-α) inactivates IRS-1 through a JNK-mediated phosphorylation of S307 (S312 in human IRS-1), which results in insulin resistance [127,131].”
Ropelle, E. R., Pauli, J. R., Prada, P. O., De Souza, C. T., Picardi, P. K., Faria, M. C., Cintra, D. E., Fernandes, M. F. D. A., Flores, M. B., Velloso, L. A., et al. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.120006 · Cited by 191
“It has been suggested that JNK contributes to insulin resistance by phosphorylating IRS-1 at Ser307, and this phosphorylation leads to inhibition of the IRS-1 function (Aguirre et al. 2000, 2002; Rui et al. 2001; Lee et al. 2003; Prattali et al. 2005).”
BackgroundInfluentialSripetchwandee, J., Chattipakorn, N., & Chattipakorn, S. C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00496 · Cited by 190
Kim, H., Haluzik, M., Asghar, Z., Yau, D., Joseph, J. W., Fernandez, A. M., Reitman, M. L., Yakar, S., Stannard, B., Heron-Milhavet, L., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1770 · Cited by 190
Lim, Y.-M., Lim, H., Hur, K. Y., Quan, W., Lee, H.-Y., Cheon, H., Ryu, D., Koo, S.-H., Kim, H. L., Kim, J., et al. (2014) · Nature Communications · doi:10.1038/ncomms5934 · Cited by 189
Yin, W., Park, J.-I., & Loeser, R. F. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.056838 · Cited by 182
Influence of TNF-α and IL-6 infusions on insulin sensitivity and expression of IL-18 in humans
Krogh-Madsen, R., Plomgaard, P., Møller, K., Mittendorfer, B., & Pedersen, B. K. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00471.2005 · Cited by 180
“This suggestion is supported by the fact that IL-18 (1, 70), like TNF (4, 9), activates c-Jun NH2-terminal kinase (JNK), which phosphorylates insulin receptor substrate-1 at serine 307 and thereby inhibits insulin action (2, 40).”
BackgroundBrachmann, S. M., Ueki, K., Engelman, J. A., Kahn, R. C., & Cantley, L. C. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.5.1596-1607.2005 · Cited by 179
“The negative feedback loop results in an increase in IRS1 Ser-307 (Ser-312 in humans) phosphorylation, decreased kinase activity of the insulin receptor, decreased IR-IRS1 interaction, increased IRS1 cytosolic distribution, increased IRS1 degradation, and decreased association between IRS1 and SH2 domain-containing pr…”
BackgroundDeconvoluting the role of reactive oxygen species and autophagy in human diseases
Wen, X., Wu, J., Wang, F., Liu, B., Huang, C., & Wei, Y. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.07.013 · Cited by 178
Insulin resistance in type 2 diabetes mellitus
Accili, D., Deng, Z., & Liu, Q. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-025-01114-y · Cited by 163
“serine–threonine kinases phosphorylate sites on the insulin receptor itself 45 and its main substrates, inhibiting insulin signalling 46 .”
JNK Activity Is Essential for Atf4 Expression and Late-Stage Osteoblast Differentiation
Matsuguchi, T., Chiba, N., Bandow, K., Kakimoto, K., Masuda, A., & Ohnishi, T. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081107 · Cited by 176
“phorylates insulin receptor substrate-1 (IRS-1) to be inactivated more preferentially than JNK2 does,((35,36)) which”
BackgroundLiu, Y., Xu, W., Zhai, T., You, J., & Chen, Y. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.02.006 · Cited by 175
The obese healthy paradox: is inflammation the answer?
Barbarroja, N., López-Pedrera, R., Mayas, M. D., García-Fuentes, E., Garrido-Sánchez, L., Macías-González, M., El Bekay, R., Vidal-Puig, A., & Tinahones, F. J. (2010) · Biochemical Journal · doi:10.1042/bj20100285 · Cited by 174
“However in the context of overnutrition induced insulin resistance, IRS-1 becomes the target substrate for multiple proinflammatory serine kinases [6, 7].”
BackgroundcJun NH2-terminal kinase 1 (JNK1): Roles in metabolic regulation of insulin resistance
Sabio, G., & Davis, R. J. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.04.004 · Cited by 170
“However, this conclusion contrasts with previous observations concerning IRS1 phosphorylation on Ser-307 [27–29] and raises questions concerning possible tissue-specific roles of IRS1 Ser-307 phosphorylation.”
BackgroundResultCiccarelli, M., Chuprun, J. K., Rengo, G., Gao, E., Wei, Z., Peroutka, R. J., Gold, J. I., Gumpert, A., Chen, M., Otis, N. J., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.988642 · Cited by 170
Giani, J. F., Mayer, M. A., Muñoz, M. C., Silberman, E. A., Höcht, C., Taira, C. A., Gironacci, M. M., Turyn, D., & Dominici, F. P. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90678.2008 · Cited by 170
Kaempferol alleviates insulin resistance via hepatic IKK/NF-κB signal in type 2 diabetic rats
Luo, C., Yang, H., Tang, C., Yao, G., Kong, L., He, H., & Zhou, Y. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.07.018 · Cited by 169
Banerjee, S., Saito, K., Ait-Goughoulte, M., Meyer, K., Ray, R. B., & Ray, R. (2008) · Journal of Virology · doi:10.1128/jvi.01672-07 · Cited by 168
“Since a direct involvement of JNK in insulin signaling has been established (3, 4, 28), we determined the role of JNK inhibitor SP600125 (treated with 20 M for 30 min) upon IRS-1 Ser(312) phosphorylation status in the presence of HCV core protein.”
BackgroundInfluentialObesity-Related Upregulation of Monocyte Chemotactic Factors in Adipocytes
Jiao, P., Chen, Q., Shah, S., Du, J., Tao, B., Tzameli, I., Yan, W., & Xu, H. (2009) · Diabetes · doi:10.2337/db07-1344 · Cited by 166
Enhanced Mitogenic Signaling in Skeletal Muscle of Women With Polycystic Ovary Syndrome
Corbould, A., Zhao, H., Mirzoeva, S., Aird, F., & Dunaif, A. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-0453 · Cited by 166
“Phosphorylation of IRS-1 Ser(312) impairs signaling by decreasing docking of the p85 regulatory subunit of PI 3-kinase (24–26), inhibiting interaction with the insulin receptor (26) and promoting degradation of IRS-1 (34).”
BackgroundInsulin signaling and glucose transport in insulin resistant human skeletal muscle
Karlsson, H. K. R., & Zierath, J. R. (2007) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-007-0030-9 · Cited by 159
Morgan, S. A., Sherlock, M., Gathercole, L. L., Lavery, G. G., Lenaghan, C., Bujalska, I. J., Laber, D., Yu, A., Convey, G., Mayers, R., et al. (2009) · Diabetes · doi:10.2337/db09-0525 · Cited by 167
“Serine/threonine phosphorylation of IRS1 (in particular Ser(307) phosphorylation) has been shown to negatively regulate insulin signaling through multiple mechanisms including decreased affinity for the insulin receptor and increased degradation (9,10).”
Tang, X., Guilherme, A., Chakladar, A., Powelka, A. M., Konda, S., Virbasius, J. V., Nicoloro, S. M. C., Straubhaar, J., & Czech, M. P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507660103 · Cited by 164
Influence of Gut Microbiota on Subclinical Inflammation and Insulin Resistance
Carvalho, B. M., & Abdalla Saad, M. J. (2013) · Mediators of Inflammation · doi:10.1155/2013/986734 · Cited by 163
“However, over the last ten years, this community that lives within the mammalian body has been gaining the status of a microbial organ that contributes to homeostasis and impacts directly on energy metabolism and insulin sensitivity [12, 13].”
BackgroundFederici, M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26052 · Cited by 163
“This serine phosphorylation reduces the ability of IRS-1 to be tyrosine phosphorylated by the Insr, a step required for insulin metabolic action such as glucose transport (18).”
BackgroundSzczepankiewicz, B. G., Kosogof, C., Nelson, L. T. J., Liu, G., Liu, B., Zhao, H., Serby, M. D., Xin, Z., Liu, M., Gum, R. J., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060199b · Cited by 159
Mori, H., Prestwich, T. C., Reid, M. A., Longo, K. A., Gerin, I., Cawthorn, W. P., Susulic, V. S., Krishnan, V., Greenfield, A., & MacDougald, O. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63604 · Cited by 162
Muscular diacylglycerol metabolism and insulin resistance
Timmers, S., Schrauwen, P., & de Vogel, J. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.12.002 · Cited by 161
Schmitz-Peiffer, C., & Biden, T. J. (2008) · Diabetes · doi:10.2337/db07-1769 · Cited by 158
“Thus, PKC activation may enhance the ability of kinases, such as Jun NH2-terminal kinase (JNK) and inhibitor of B kinase (IKK)- , to phosphorylate IRS-1 at Ser-307, a key regulatory site located close to the domain that interacts with the insulin receptor (27).”
BackgroundVascular endothelium dysfunction: a conservative target in metabolic disorders
Jamwal, S., & Sharma, S. (2018) · Inflammation Research · doi:10.1007/s00011-018-1129-8 · Cited by 159
Mingo-Sion, A. M., Marietta, P. M., Koller, E., Wolf, D. M., & Berg, C. L. V. D. (2004) · Oncogene · doi:10.1038/sj.onc.1207147 · Cited by 169
“These findings suggest a possible explanation for JNK’s inhibitory effect on growth of cells in anchorage-independent growth and insulin resistance (Aguirre et al., 2000, 2002; Mamay et al., 2003).”
BackgroundInsulin resistance induced by tumor necrosis factor-α in myocytes and brown adipocytes12
Lorenzo, M., Fernández-Veledo, S., Vila-Bedmar, R., Garcia-Guerra, L., De Alvaro, C., & Nieto-Vazquez, I. (2008) · Journal of Animal Science · doi:10.2527/jas.2007-0462 · Cited by 156
Insulin Resistance and Mitochondrial Dysfunction
González-Franquesa, A., & Patti, M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-55330-6_25 · Cited by 176
Mammalian target of rapamycin regulates IRS-1 serine 307 phosphorylation
Carlson, C. J., White, M. F., & Rondinone, C. M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.02.082 · Cited by 157
“Serine 307 phosphorylation can be induced by factors such as cellular stressors [7,8,10], insulin [7,11], TNF-a [11], and lipids [12], all factors that cause insulin resistance.”
BackgroundInfluentialSelf-citationEckardt, K., Sell, H., Taube, A., Koenen, M., Platzbecker, B., Cramer, A., Horrighs, A., Lehtonen, M., Tennagels, N., & Eckel, J. (2008) · Diabetologia · doi:10.1007/s00125-008-1240-4 · Cited by 167
TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice
Wandrer, F., Liebig, S., Marhenke, S., Vogel, A., John, K., Manns, M. P., Teufel, A., Itzel, T., Longerich, T., Maier, O., et al. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2411-6 · Cited by 152
The Genetic Basis of Type 2 Diabetes.
Das, S. K., & Elbein, S. C. (2006) · PubMed · doi:10.1901/jaba.2006.2-100 · Cited by 152
Nonalcoholic fatty liver disease: A main driver of insulin resistance or a dangerous liaison?
Gruben, N., Shiri‐Sverdlov, R., Koonen, D. P. Y., & Hofker, M. H. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.08.004 · Cited by 167
“When IRS1 is phosphorylated in this way, the insulin signaling pathway is inhibited [76, 77].”
BackgroundMediators of cytokine-induced insulin resistance in obesity and other inflammatory settings
Marette, A. (2002) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200207000-00005 · Cited by 149
Lactoferrin in aseptic and septic inflammation
Lepanto, M. S., Rosa, L., Paesano, R., Valenti, P., & Cutone, A. (2019) · Molecules · doi:10.3390/molecules24071323 · Cited by 147
“This phosphorylation reduces the ability of IRS-1 to associate with the insulin receptor thus inhibiting the insulin action [139,141,142].”
BackgroundGual, P., Grémeaux, T., Gonzalez, T., MARCHAND‐BRUSTEL, Y. L., & Tanti, J. (2003) · Diabetologia · doi:10.1007/s00125-003-1223-4 · Cited by 343
Song, P., Wu, Y., Xu, J., Xie, Z., Dong, Y., Zhang, M., & Zou, M.-H. (2007) · Circulation · doi:10.1161/circulationaha.107.716498 · Cited by 143
RetractedWeigert, C., Hennige, A. M., Lehmann, R., Brodbeck, K., Baumgartner, F., Schaüble, M., Häring, H. U., & Schleicher, E. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509782200 · Cited by 141
Caricilli, A. M., Nascimento, P. H., Pauli, J. R., Tsukumo, D. M. L., Velloso, L. A., Carvalheira, J. B., & Saad, M. J. A. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0354 · Cited by 141
Yahoo, N., Dudek, M., Knolle, P., & Heikenwälder, M. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.02.033 · Cited by 137
Lin, C., & Lin, J. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700437 · Cited by 148
Yang, Y. M., Seo, S. Y., Kim, T. H., & Kim, S. G. (2012) · Hepatology · doi:10.1002/hep.25912 · Cited by 151
“The phosphorylation of IRS1/2 at Ser312 in human, corresponding to Ser307 in rodents, is a marker of insulin resistance.(17) Treatment of HFD-fed mice with IsoLQ or LQ caused a decrease in IRS1 phosphorylation at Ser307 (Fig.”
BackgroundSutton, G. M., Trevaskis, J. L., Hulver, M. W., McMillan, R. P., Markward, N. J., Babin, M. J., Meyer, E. A., & Butler, A. A. (2006) · Endocrinology · doi:10.1210/en.2005-1209 · Cited by 139
“Insulin resistance was assessed by measuring the phosphorylation of insulin receptor substrate 1 (IRS1) on Ser307, which inhibits association of IRS1 with the insulin receptor tyrosine kinase (30).”
BackgroundMethodPhysical inactivity and obesity: links with insulin resistance and type 2 diabetes mellitus
Venables, M. C., & Jeukendrup, A. E. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.983 · Cited by 137
“[52] have shown that phosphorylation on a specific serine site, serine 307, of IRS-1 can block the phospho tyrosine binding domain functions of the IRS-1 protein thereby inhibiting the downstream signaling events such as PI3kinase activation.”
BackgroundHenriksen, E. J. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.04.002 · Cited by 136
Regulatory mechanisms and functions of MAP kinase signaling pathways
Imajo, M., Tsuchiya, Y., & Nishida, E. (2006) · IUBMB Life · doi:10.1080/15216540600746393 · Cited by 137
“Moreover, JNK1 interferes with insulin signaling by phosphorylating the adaptor protein, insulin receptor substrate 1 (IRS-1) in cultured cells ( 37, 38, 40 ).”
BackgroundBrain insulin resistance: A treatment target for cognitive impairment and anhedonia in depression
Hamer, J. A., Testani, D., Mansur, R. B., Lee, Y., Subramaniapillai, M., & McIntyre, R. S. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.01.016 · Cited by 136
Self-citationInsulin receptor substrate proteins and diabetes
Lee, Y. H., & White, M. F. (2004) · Archives of Pharmacal Research · doi:10.1007/bf02980074 · Cited by 153
Self-citationOliver, E., McGillicuddy, F., Phillips, C., Toomey, S., & Roche, H. M. (2010) · Proceedings of the Nutrition Society · doi:10.1017/s0029665110000042 · Cited by 136
“Interestingly, activation of c-Jun N-terminal kinase by pro-inflammatory cytokines inhibits insulin signalling, at least in part, by stimulating phosphorylation of IRS-1 at Ser307 (in mice) and Ser312 (in human subjects)((26,27)).”
Innate Immune Cells in the Adipose Tissue in Health and Metabolic Disease
Michailidou, Z., Gomez-Salazar, M. A., & Alexaki, V. I. (2021) · Journal of Innate Immunity · doi:10.1159/000515117 · Cited by 159
Sun, X., Lin, J., Zhang, Y., Kang, S., Belkin, N., Wara, A. K., Icli, B., Hamburg, N. M., Li, D., & Feinberg, M. W. (2016) · Circulation Research · doi:10.1161/circresaha.115.308166 · Cited by 135
Fatty acids and chronic low grade inflammation associated with obesity and the metabolic syndrome
Cooke, A. A., Connaughton, R. M., Lyons, C. L., McMorrow, A. M., & Roche, H. M. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.04.021 · Cited by 151
Longato, L., Ripp, K., Setshedi, M., Dostalek, M., Akhlaghi, F., Branda, M., Wands, J. R., & de la Monte, S. M. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/479348 · Cited by 133
“S312 phosphorylation of IRS-1 inhibits IRS-1 signaling [42].”
BackgroundMetabolic Stress Signaling Mediated by Mixed-Lineage Kinases
Jaeschke, A., & Davis, R. J. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.07.008 · Cited by 150
“One molecular mechanism that contributes to JNK-induced insulin resistance is the phosphorylation of the insulin receptor adaptor protein IRS1 on the inhibitory site Ser-307 (Aguirre et al., 2000, 2002; Lee et al., 2003).”
BackgroundImpact of mitochondrial ROS production in the pathogenesis of insulin resistance
Nishikawa, T., Kukidome, D., Sonoda, K., Fujisawa, K., Matsuhisa, T., Motoshima, H., Matsumura, T., & Araki, E. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.01.071 · Cited by 144
AKT Signaling in Physiology and Disease
Vasudevan, K. M., & Garraway, L. A. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_66 · Cited by 153
Two Tales of Antioxidant Enzymes on β Cells and Diabetes
Lei, X. G., & Vatamaniuk, M. Z. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3416 · Cited by 159
“Activation of JNK increased phosphorylation of insulin receptor substrate-1 (IRS-1) on Ser 307 that disrupted the interaction between the catalytic domain of the insulin receptor and the phosphotyrosine binding domain of IRS-1 (1, 2).”
Moeschel, K., Beck, A., Weigert, C., Lammers, R., Kalbacher, H., Voelter, W., Schleicher, E. D., Häring, H.-U., & Lehmann, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402477200 · Cited by 128
Disruption of the SH2-B Gene Causes Age-Dependent Insulin Resistance and Glucose Intolerance
Duan, C., Yang, H., White, M. F., & Rui, L. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.17.7435-7443.2004 · Cited by 126
Self-citation
Metadata
- Authors
- Aguirre, V., Werner, E. D., Giraud, J., Lee, Y. H., Shoelson, S. E., & White, M. F.
- Affiliations
- Joslin Diabetes Center (US)
- Corresponding author
- White, Morris F.
- ORCID
- White, Morris F.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-01
- Volume
- 277
- Issue
- 2
- Pages
- 1531-1537
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1972590376
- Cited by
- 1,010
- References
- 55
- Citations by year
- 2026: 27 · 2025: 24 · 2024: 26 · 2023: 25 · 2022: 27 · 2021: 35 · 2020: 30 · 2019: 43 · 2018: 41 · 2017: 33 · 2016: 40 · 2015: 36 · 2014: 57 · 2013: 45 · 2012: 58
- FWCI
- 15.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6852 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- IRS-1, insulin resistance, insulin signaling, phosphotyrosine binding domain, insulin receptor, JNK1, MAPK signaling, phosphatidylinositol 3-kinase, protein-protein interaction inhibition
- MeSH terms
- Animals, Anisomycin, Anti-Bacterial Agents, Cell Line, Humans, Insulin, Phosphoproteins, Phosphorylation, Receptor, Insulin, Recombinant Fusion Proteins, Tumor Necrosis Factor-alpha, Signal Transduction, Phosphatidylinositol 3-Kinases, Two-Hybrid System Techniques, Mitogen-Activated Protein Kinases, Mitogen-Activated Protein Kinase 8, Rats, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.